Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Feb 2019 – 20 Aug 2026, limited by Shriram ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Shriram ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 01 Feb 2019 | ₹100.00 | ₹100.00 |
| 19 Sep 2019 | ₹101.24 | ₹96.80 |
| 06 May 2020 | ₹96.29 | ₹83.65 |
| 21 Dec 2020 | ₹128.75 | ₹121.07 |
| 08 Aug 2021 | ₹151.80 | ₹154.09 |
| 26 Mar 2022 | ₹157.61 | ₹161.78 |
| 11 Nov 2022 | ₹171.84 | ₹172.80 |
| 28 Jun 2023 | ₹176.71 | ₹179.73 |
| 13 Feb 2024 | ₹223.93 | ₹218.44 |
| 30 Sep 2024 | ₹267.10 | ₹267.72 |
| 18 May 2025 | ₹230.57 | ₹252.54 |
| 02 Jan 2026 | ₹245.89 | ₹266.10 |
| 20 Aug 2026 | ₹239.75 | ₹259.63 |
| Metric | Shriram · Direct NAV ₹23.99 Very High risk ★☆☆☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| +0.95% | +3.05% | |
| +9.45% | +14.46% | |
| +9.37% | +13.60% | |
| — | +13.74% | |
| +12.28% | +14.97% | |
| +7.59% | — | |
| +15.11% | +16.84% | |
| +15.45% | +17.15% | |
| — | +15.41% | |
| Risk | ||
| 15.62% | 14.19% | |
| 0.19 | 0.52 | |
| 0.25 | 0.70 | |
| -29.78% | -35.94% | |
| Nifty 500 | — | |
| -1.94% | +1.57% | |
| 1.00 | 0.97 | |
| 98.5% | 102.3% | |
| 112.0% | 93.6% | |
| 0.94% | 1.06% | |
| ₹46.00Cr | ₹765.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 32% | 34% | |
| Deepak Ramaraju | — | |
| 01 Feb 2019 | — | |
| 70 | — | |
| 39.3% | — | |
| 1.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.